Gérald Simonneau

115.0k total citations · 28 hit papers
567 papers, 58.8k citations indexed

About

Gérald Simonneau is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Gérald Simonneau has authored 567 papers receiving a total of 58.8k indexed citations (citations by other indexed papers that have themselves been cited), including 499 papers in Pulmonary and Respiratory Medicine, 243 papers in Cardiology and Cardiovascular Medicine and 133 papers in Genetics. Recurrent topics in Gérald Simonneau's work include Pulmonary Hypertension Research and Treatments (475 papers), Cardiovascular Issues in Pregnancy (126 papers) and Vascular Anomalies and Treatments (114 papers). Gérald Simonneau is often cited by papers focused on Pulmonary Hypertension Research and Treatments (475 papers), Cardiovascular Issues in Pregnancy (126 papers) and Vascular Anomalies and Treatments (114 papers). Gérald Simonneau collaborates with scholars based in France, United States and Germany. Gérald Simonneau's co-authors include Marc Humbert, Olivier Sitbon, Nazzareno Galiè, Lewis J. Rubin, David Montani, Xavier Jaïs, Rogério Souza, Florence Parent, Philippe Hervé and Hossein Ardeschir Ghofrani and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Gérald Simonneau

547 papers receiving 56.9k citations

Hit Papers

Updated Clinical Classification of ... 1995 2026 2005 2015 2013 2018 2002 2009 2006 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Updated Clinical Classification of Pulmonary Hypertension
    2013 2.5k citations Gérald Simonneau, Hossein Ardeschir Ghofrani et al. profile →
  2. Haemodynamic definitions and updated clinical classification of pulmonary hypertension
    2018 2.4k citations Gérald Simonneau, David Montani et al. European Respiratory Journal profile →
  3. Bosentan Therapy for Pulmonary Arterial Hypertension
    2002 2.0k citations Lewis J. Rubin, Robyn J. Barst et al. New England Journal of Medicine profile →
  4. Updated Clinical Classification of Pulmonary Hypertension
    2009 1.5k citations Gérald Simonneau, Rogério Souza et al. profile →
  5. Pulmonary Arterial Hypertension in France
    2006 1.4k citations Marc Humbert, Olivier Sitbon et al. American Journal of Respiratory and Critical Care Medicine profile →
  6. Clinical classification of pulmonary hypertension
    2004 1.3k citations Gérald Simonneau, Nazzareno Galiè et al. profile →
  7. Treatment of Pulmonary Arterial Hypertension
    2004 1.3k citations Marc Humbert, Olivier Sitbon et al. New England Journal of Medicine profile →
  8. Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
    1995 1.3k citations Laurent Brochard, Jordi Mancebo et al. New England Journal of Medicine profile →
  9. A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
    1998 1.2k citations Florence Parent, Gérald Simonneau et al. New England Journal of Medicine profile →
  10. Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial
    2002 1.1k citations Gérald Simonneau, Robyn J. Barst et al. American Journal of Respiratory and Critical Care Medicine profile →
  11. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
    2002 1.0k citations Olivier Sitbon, Marc Humbert et al. profile →
  12. Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
    2013 948 citations Nazzareno Galiè, Hossein Ardeschir Ghofrani et al. New England Journal of Medicine profile →
  13. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
    2013 911 citations Hossein Ardeschir Ghofrani, Friedrich Grimminger et al. New England Journal of Medicine profile →
  14. Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension
    1996 813 citations Stuart Rich, Gérald Simonneau et al. New England Journal of Medicine profile →
  15. Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
    1996 810 citations Gérald Simonneau et al. New England Journal of Medicine profile →
  16. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
    2005 797 citations Olivier Sitbon, Marc Humbert et al. Circulation profile →
  17. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
    2015 750 citations Nazzareno Galiè, Adaani Frost et al. New England Journal of Medicine profile →
  18. Selexipag for the Treatment of Pulmonary Arterial Hypertension
    2015 706 citations Olivier Sitbon, Kelly Chin et al. New England Journal of Medicine profile →
  19. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial
    2008 647 citations Nazzareno Galiè, Marius M. Hoeper et al. profile →
  20. Medical Therapy For Pulmonary Arterial Hypertension
    2004 634 citations Robyn J. Barst, Gérald Simonneau et al. profile →
  21. Increased Interleukin-1 and Interleukin-6 Serum Concentrations in Severe Primary Pulmonary Hypertension
    1995 622 citations Marc Humbert, Olivier Sitbon et al. American Journal of Respiratory and Critical Care Medicine profile →
  22. A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary Embolism
    1997 555 citations Gérald Simonneau et al. New England Journal of Medicine profile →
  23. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry
    2011 479 citations Gérald Simonneau, Philippe Dartevelle et al. profile →
  24. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
    2017 441 citations Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal profile →
  25. Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
    2015 437 citations Benoît Ranchoux, Fabrice Antigny et al. Circulation profile →
  26. Increased plasma serotonin in primary pulmonary hypertension
    1995 428 citations Jean‐Marie Launay, Gérald Simonneau et al. profile →
  27. Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
    2013 411 citations Marius M. Hoeper, Robyn J. Barst et al. Circulation profile →
  28. The pathophysiology of chronic thromboembolic pulmonary hypertension
    2017 290 citations Gérald Simonneau, Peter Dorfmüller et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gérald Simonneau France 116 48.1k 30.4k 10.0k 7.9k 6.6k 567 58.8k
Marc Humbert France 123 48.9k 1.0× 22.2k 0.7× 8.2k 0.8× 7.7k 1.0× 1.8k 0.3× 1.0k 61.9k
Lewis J. Rubin United States 89 31.7k 0.7× 22.0k 0.7× 6.1k 0.6× 4.3k 0.5× 1.2k 0.2× 332 37.9k
Hossein Ardeschir Ghofrani Germany 86 27.9k 0.6× 17.9k 0.6× 4.5k 0.4× 3.5k 0.4× 1.2k 0.2× 635 34.8k
Olivier Sitbon France 84 24.9k 0.5× 14.8k 0.5× 5.4k 0.5× 3.5k 0.4× 961 0.1× 460 27.7k
Robyn J. Barst United States 82 30.6k 0.6× 21.2k 0.7× 6.6k 0.7× 4.0k 0.5× 582 0.1× 250 34.2k
Marius M. Hoeper Germany 85 22.0k 0.5× 14.7k 0.5× 3.8k 0.4× 4.0k 0.5× 1.3k 0.2× 464 27.0k
Nazzareno Galiè Italy 76 24.2k 0.5× 17.4k 0.6× 4.7k 0.5× 2.6k 0.3× 906 0.1× 409 27.7k
Victor F. Tapson United States 79 15.4k 0.3× 16.0k 0.5× 2.9k 0.3× 5.2k 0.7× 11.3k 1.7× 339 29.6k
Michael D. McGoon United States 70 22.6k 0.5× 18.2k 0.6× 3.8k 0.4× 4.3k 0.5× 682 0.1× 176 28.5k
David B. Badesch United States 62 23.3k 0.5× 15.2k 0.5× 4.5k 0.4× 3.0k 0.4× 556 0.1× 180 25.9k

Countries citing papers authored by Gérald Simonneau

Since Specialization
Citations

This map shows the geographic impact of Gérald Simonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Simonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Simonneau more than expected).

Fields of papers citing papers by Gérald Simonneau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérald Simonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Simonneau. The network helps show where Gérald Simonneau may publish in the future.

Co-authorship network of co-authors of Gérald Simonneau

This figure shows the co-authorship network connecting the top 25 collaborators of Gérald Simonneau. A scholar is included among the top collaborators of Gérald Simonneau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérald Simonneau. Gérald Simonneau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khouri, Charles, Xavier Jaïs, Laurent Savale, et al.. (2024). Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors. European Respiratory Journal. 63(6). 2302158–2302158. 7 indexed citations
2.
Galiè, Nazzareno, Olivier Sitbon, Martin Doelberg, et al.. (2020). Long-term outcomes in newly diagnosed pulmonary arterial hypertension (PAH) patients receiving initial triple oral combination therapy: insights from the randomised controlled TRITON study. European Heart Journal. 41(Supplement_2). 2 indexed citations
3.
Turpin, Matthieu, Florence Parent, Françoise Driss, et al.. (2018). Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease. European Respiratory Journal. 52(4). 1800272–1800272. 17 indexed citations
4.
Weatherald, Jason, Athénaïs Boucly, D. S. Chemla, et al.. (2017). Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Circulation. 137(7). 693–704. 141 indexed citations
5.
Ranchoux, Benoît, Fabrice Antigny, Catherine Rücker‐Martin, et al.. (2015). Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension. Circulation. 131(11). 1006–1018. 437 indexed citations breakdown →
6.
Sattler, C.H., Hélène Bouvaist, Xavier Jaïs, et al.. (2013). Outcome of candidates for liver transplantation suffering from portopulmonary hypertension. European Respiratory Journal. 42(Suppl 57). P2616–P2616. 1 indexed citations
7.
Hoeper, Marius M., Robyn J. Barst, Robert C. Bourge, et al.. (2013). Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension. Circulation. 127(10). 1128–1138. 411 indexed citations breakdown →
8.
Man, Frances S. de, Ly Tu, M. Louis Handoko, et al.. (2012). Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(8). 780–789. 252 indexed citations
9.
Montani, David, Frédéric Perros, Natalia Gambaryan, et al.. (2011). C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 184(1). 116–123. 165 indexed citations
10.
Perros, Frédéric, David Montani, Peter Dorfmüller, et al.. (2008). Platelet-derived Growth Factor Expression and Function in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(1). 81–88. 357 indexed citations
11.
Sitbon, Olivier, Caroline Lascoux‐Combe, Jean‐François Delfraissy, et al.. (2007). Prevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era. American Journal of Respiratory and Critical Care Medicine. 177(1). 108–113. 322 indexed citations
12.
Eddahibi, Saadia, Christophe Guignabert, Anne‐Marie Barlier‐Mur, et al.. (2006). Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension. Circulation. 113(15). 1857–1864. 230 indexed citations
13.
Dewachter, Laurence, Serge Adnot, Élie Fadel, et al.. (2006). Angiopoietin/Tie2 Pathway Influences Smooth Muscle Hyperplasia in Idiopathic Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 174(9). 1025–1033. 92 indexed citations
14.
Sitbon, Olivier, Virginie Gressin, Rudolf Speich, et al.. (2004). Bosentan for the Treatment of Human Immunodeficiency Virus–associated Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 170(11). 1212–1217. 180 indexed citations
15.
Simonneau, Gérald, Robyn J. Barst, Nazzareno Galiè, et al.. (2002). Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial. American Journal of Respiratory and Critical Care Medicine. 165(6). 800–804. 1052 indexed citations breakdown →
16.
Nunès, Hilario, Didier Lebrec, Michel Mazmanian, et al.. (2001). Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats. American Journal of Respiratory and Critical Care Medicine. 164(5). 879–885. 142 indexed citations
17.
Eddahibi, Saadia, Marc Humbert, Saı̈d Sediame, et al.. (2000). Imbalance between Platelet Vascular Endothelial Growth Factor and Platelet-derived Growth Factor in Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 162(4). 1493–1499. 83 indexed citations
18.
Fraisse, F, Laurent Holzapfel, Gérald Simonneau, et al.. (2000). Nadroparin in the Prevention of Deep Vein Thrombosis in Acute Decompensated COPD. American Journal of Respiratory and Critical Care Medicine. 161(4). 1109–1114. 223 indexed citations
19.
Archer, Stephen L., Marc Humbert, Ε. Kenneth Weir, et al.. (1998). Nitric Oxide Deficiency in Fenfluramine- and Dexfenfluramine-induced Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 158(4). 1061–1067. 84 indexed citations
20.
Brochard, Laurent, Jordi Mancebo, Marc Wysocki, et al.. (1995). Noninvasive Ventilation for Acute Exacerbations of Chronic Obstructive Pulmonary Disease. New England Journal of Medicine. 333(13). 817–822. 1273 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Humbert Breakdown of academic impact, for papers by Lewis J. Rubin Breakdown of academic impact, for papers by Hossein Ardeschir Ghofrani Breakdown of academic impact, for papers by Olivier Sitbon Breakdown of academic impact, for papers by Robyn J. Barst Breakdown of academic impact, for papers by Marius M. Hoeper Breakdown of academic impact, for papers by Nazzareno Galiè Breakdown of academic impact, for papers by Victor F. Tapson Breakdown of academic impact, for papers by Michael D. McGoon Breakdown of academic impact, for papers by David B. Badesch
Rankless by CCL
2026